Skip to search formSkip to main contentSkip to account menu
Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.
PURPOSE To analyze outcomes of hematopoietic cell transplantation (HCT) in T-cell non-Hodgkin lymphoma. PATIENTS AND METHODS Outcomes of 241 patients (112 anaplastic large-cell lymphoma, 102…
View on PubMed
High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: long-term follow-up of the US multicenter pilot study.
TLDR
Sustained responses including a decrease in dermal fibrosis were observed exceeding those previously reported with other therapies, and HDIT and autologous HCT for SSc should be evaluated in a randomized clinical trial.
View on PubMed
Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
TLDR
The NCCN Multiple Myeloma Panel members have developed guidelines for the management of patients with various plasma cell dyscrasias, including solitary plasmacytoma, smoldering myeloma, multiple myelomas, systemic light chain amyloidosis, and Waldenström's macroglobulinemia.
View on PubMed
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.
TLDR
Important clinical issues in the use of HDIT and stem cell transplantation for MS were identified; however, modifications of the initial approaches appear to reduce treatment risks.
View on PubMed
Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality.
TLDR
For patients with chemotherapy-sensitive MCL, the optimal timing for HCT is early in the disease course, and outcomes are particularly favorable for patients undergoing auto-HCT in first complete remission.
View on PubMed
Multiple Myeloma, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology.
TLDR
This manuscript discusses the management of patients with solitary plasmacytoma, smoldering multiple Myeloma, and newly diagnosed multiple myeloma.
View on PubMed
NCCN Guidelines Insights: Multiple Myeloma, Version 1.2020.
The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, workup, treatment, follow-up, and supportive care for patients with monoclonal gammopathy of renal significance,…
View on PubMed
NCCN Guidelines Insights: Multiple Myeloma, Version 3.2016.
These NCCN Guidelines Insights highlight the important updates/changes specific to the 2016 version of the NCCN Clinical Practice Guidelines in Oncology for Multiple Myeloma. These changes include…
View on PubMed
Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome.
View on PubMed
Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation.
TLDR
The incidence of viral and bacterial infections appears to be increased in recipients of CD34-selected autologous PBSC transplants, and infection surveillance, diagnostic work-up, and prevention strategies similar to those used in allogeneic recipients are warranted.
View on PubMed
...
...
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License